ResearcherFirst Affiliated Hospital of Xi'an Jiaotong UniversityNo recent work listed

Lu Bai

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0008-7986-0957; OpenAlex author ID A5109299100. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 2

Papers, trials and grants by year

2020: 2 papers

Papers 2

DRP1 upregulation promotes pancreatic cancer growth and metastasis through increased aerobic glycolysis. Co-author DOI 10.1111/jgh.14912 ↗
Downregulation of MiD49 contributes to tumor growth and metastasis of human pancreatic cancer. Co-author DOI 10.3892/or.2020.7499 ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Enxiao Li · 2 shared papers, 2020 · strength 0.31
- Paper Downregulation of MiD49 contributes to tumor growth and metastasis of human pancreatic cancer. DOI 10.3892/or.2020.7499 ↗
- Paper DRP1 upregulation promotes pancreatic cancer growth and metastasis through increased aerobic glycolysis. DOI 10.1111/jgh.14912 ↗
Jing Liang · 2 shared papers, 2020 · strength 0.31
- Paper Downregulation of MiD49 contributes to tumor growth and metastasis of human pancreatic cancer. DOI 10.3892/or.2020.7499 ↗
- Paper DRP1 upregulation promotes pancreatic cancer growth and metastasis through increased aerobic glycolysis. DOI 10.1111/jgh.14912 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.